Navigation Links
Nutricia launches Nutra Neocate, weaning product designed for cows’ milk protein allergy
Date:6/11/2009

First and only weaning product based on 100% non-allergenic amino-acids specifically designed for children with Cows' Milk Protein Allergy and Multiple Food Protein Intolerance

Nutricia launches Neocate Nutra at the European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN)

Liverpool, UK, 11th June 2009: Nutricia, the European market leader in advanced medical nutrition, announces the launch of Neocate Nutra, the first and only weaning product made from 100% non-allergenic amino acids. Neocate Nutra has been specifically developed for weaning infants and older children with cows' milk protein allergy (CMPA) and multiple food protein intolerance (MFPI). Unlike many weaning products, Neocate Nutra contains no hidden allergens and is designed to provide children with the key essential nutrients they need for development. With its unique format, Neocate Nutra is suitable for taking infants through the various stages of weaning and also for older children on very restricted diets who are looking for convenient and varied food options.

Neocate Nutra represents a groundbreaking advance in the management of CMPA, a condition which affects between 2 to 7.5% of infants worldwide.1 With the launch of Neocate Nutra, parents of CMPA infants of a weaning age and above can, for the first time, choose with confidence a weaning product that is made from 100% non-allergenic amino acids, ruling out any possible allergic reactions caused by an exposure to any trace of cows' milk. Neocate Nutra contains key essential nutrients potentially missing from a dairy-free diet and contains a child's full dietary requirements of calcium and two thirds of their daily requirements for iron and vitamin D*. This helps to ensure valuable nutrition for healthy bones, growth and development throughout the weaning stage and beyond.

"The weaning stage can be nerve-wracking for parents of infants with cows' milk protein allergy as there is often a fear that they may react to other foods. Having a weaning product that is totally milk-free and can be used to provide infants with new tastes and textures means one less thing for parents to worry about." said Dr. Adam Fox, Consultant & Honorary Senior Lecturer in Paediatric Allergy, Evelina Children's Hospital, Guy's and St Thomas', London.

Standard weaning foods available potentially contain allergens such as milk, wheat and gluten. The use of unmodified mammalian milk or unmodified soy or rice milk, is not recommended for infants as these milks are not adequately nutritious.2 In addition, soy can also present cross-reaction risks.1,3

Good nutrition is not only essential for a child's physical and emotional well-being, but also provides weaning infants with a choice and variety of different foods, tastes and textures they need to help with their mouth and tongue co-ordination for speech development.4

"We are delighted to introduce Neocate Nutra as the first and only amino acid-based weaning product for children with cows' milk allergy and other food allergies." commented Martin Pettifor, Category Director for Allergy Relief at Nutricia. "Neocate Nutra has been developed as a direct result of feedback from parents.5 Parents of children with food allergies can now wean their child with Neocate Nutra without fear of exposure to hidden allergens that can cause an allergic reaction."


'/>"/>

Contact: Emma Gilbert
emma.gilbert@cohnwolfe.com
44-207-733-12325
Cohn & Wolfe Healthcare, London
Source:Eurekalert  

Related biology news :

1. Swiss Initiative in Systems Biology launches new projects
2. Springer launches StemCellGateway.net
3. Springer launches SpringerExemplar.com
4. UC Davis launches One Health care for wild mountain gorillas and human neighbors
5. Futronic Launches FS90 USB2.0 Mini Fingerprint Scanner
6. Futronic Launches FS90 USB2.0 Mini Fingerprint Scanner
7. Iowa State chemist synthesizes carbohydrates, launches startup company
8. LabRoots Launches Social Networking Site for Scientists & Engineers
9. Stanford launches $100 million initiative to tackle energy issues
10. From sheet metal elements to host cells: DFG launches 10 new collaborative research centers
11. Springer launches Food Security
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Nutricia launches Nutra Neocate, weaning product designed for cows’ milk protein allergy
(Date:2/8/2017)... 2017 Report Highlights The global ... $8.3 billion in 2016 at a compound annual growth ... Report Includes - An overview of the global market ... data from 2015 and 2016, and projections of compound ... the market on the basis of product type, source, ...
(Date:2/6/2017)... Feb. 6, 2017 According to Acuity ... driving border authorities to continue to embrace biometric ... are 2143 Automated Border Control (ABC) eGates and ... at more than 163 ports of entry across ... 2016 achieving a combined CAGR of 37%. APC ...
(Date:2/2/2017)... , Feb. 2, 2017  EyeLock LLC, a ... a new white paper " What You Should Know ... problem of ensuring user authenticity is a growing concern. ... authentication of users. However, traditional authentication schemes such as ... Biometric authentication offers an elegant solution to ...
Breaking Biology News(10 mins):
(Date:2/16/2017)... , Feb. 16, 2017  ArmaGen, Inc., ... groundbreaking therapies to treat severe neurological disorders, today ... treated with AGT-181, the company,s investigational therapy for ... known as mucopolysaccharidosis type I, or MPS I). ... proof-of-concept (POC) study, presented today at the 13 ...
(Date:2/16/2017)... , Feb. 16, 2017   Biostage, Inc. ... "Company"), a biotechnology company developing bioengineered organ implants to ... bronchus and trachea, announced today the closing on February ... 20,000,000 shares of common stock and warrants to purchase ... of $8.0 million. The offering was priced at $0.40 ...
(Date:2/16/2017)...  Dermata Therapeutics, LLC, a biotechnology company developing ... of dermatological diseases, today announced it has completed ... into a $5 million credit facility with Silicon ... capital for general corporate purposes to further Dermata,s ... of serious diseases treated by dermatologists.   ...
(Date:2/16/2017)... 2017  Windtree Therapeutics, Inc. (Nasdaq: ... aerosolized KL4 surfactant therapies for respiratory diseases, announced ... showed that aerosolized KL4 surfactant reduced lung inflammation ... animal model. The Company believes that these preclinical ... that supports the role of KL4 surfactant as ...
Breaking Biology Technology: